$CYCUW

Cycurion (CYCU) shares rose 15% after announcing a $1M strategic partnership with a Fortune 500 company. The multi-year deal covers AI, security, and support. CYCU stock breached its 50-DMA for the first time since November 2025. The company expects growth and expansion opportunities.

Cycurion, Inc. (NASDAQ: CYCU) reported a $30 million annual revenue run rate, a 29.1% gross margin, and a $54.6 million 10-year contract. The company also announced a $500,000 share repurchase plan and reduced net debt by over half since 2024. Cycurion has 3.2 million outstanding shares and expects $15-$17 million in committed revenue annually through 2028.

Cycurion Inc. (CYCU) shares rose 37% in premarket trading after securing a $54.6M, 10-year contract for health IT modernization, adding to a 496% gain the prior day. The deal is expected to generate over $5M in annual revenue starting November 2026. The company reported a narrowed net loss and improved gross margins in Q1 2026. Analysts maintain a Buy rating with a $7.00 price target. Cycurion also faces a Nasdaq delisting threat for failing to meet the minimum bid price requirement, with a hear

Cycurion (CYCU) completed a 1-for-8 reverse stock split, reducing shares from 25.8M to 3.23M, effective August 28, 2026. The move aims to meet Nasdaq's minimum bid price requirements, with trading continuing under the same ticker.

Cycurion (NASDAQ: CYCU) announced a 1-for-8 reverse stock split to meet NASDAQ requirements. The company reported a gross margin increase to 29.1% and a $54.6M 10-year HHS contract. It also authorized a $500K share repurchase program and aims for profitability by Q2 2027. CEO Kevin Kelly addressed market manipulation allegations.

Cycurion (CYCU) announced a 1-for-8 reverse stock split and a 10-year, $54.6M deal with HHS, expected to generate over $5M in annual recurring revenue. The company reported improved gross margins (29.1% in Q2 2026 vs. 6.1% in Q2 2025) and reduced net debt. Management targets profitability by Q2 2027 and authorized a $500K share repurchase program.

Cycurion (NASDAQ:CYCU) reported Q2 2026 gross margin expansion to 29.1% from 6.1% in Q2 2025, reduced net debt by over half since 2024, and signed a $54.6M 10-year contract with HHS. The company expects $15M-$17M in committed revenue annually from 2026-2028 and aims for break-even operations by Q2 2027. It also completed two acquisitions and authorized a $500K share repurchase program.

Cycurion, Inc. (NASDAQ: CYCU) announced a 1-for-8 reverse stock split effective August 28, 2026, to meet Nasdaq's minimum bid price requirement. The split reduces outstanding shares from ~25.8M to ~3.2M, with fractional shares compensated in cash. Shareholder approval was obtained in July 2026.

Cycurion (CYCU) filed a Form 3 for CFO Ana Lucia Garcia, reporting no trades. The filing identifies her as an officer with no buy, sell, or derivative transactions. This is an initial beneficial ownership statement.

Cycurion, Inc. (CYCU) reported Q2 2026 revenue of $3.8M, beating estimates, with a 5X gross margin improvement. The company secured a $54.6M 10-year contract and acquired Kustom's video solutions, adding $5M in annual revenue. CYCU also announced a $500K share repurchase program and patent extensions for its security technology.